The Role of Specialized Clinical Sites in Medical Device Investigations

In clinical investigations of medical devices, selecting the right clinical site directly impacts data quality, recruitment efficiency, and regulatory compliance. These sites play a critical role in ensuring adherence to MDR, ISO 14155, and GCP requirements. Pure Clinical collaborates with facilities across Europe, the US, and China, all equipped with the infrastructure and expertise necessary for conducting clinical investigations across various therapeutic areas.

Quality Management System and Procedural Compliance

Each partner site implements and maintains a quality management system based on ISO 13485, aligned with GCP and ISO 14155. This ensures full control over source documentation, monitoring activities, and protocol/regulatory compliance.

Research Infrastructure and Team Competency

Sites are equipped with certified medical equipment, sample storage facilities, and compliant EDC systems that meet clinical data management standards. Clinical teams (PIs, coordinators, support staff) undergo continuous training in GCP, MDR, and study monitoring, ensuring methodological consistency and participant safety.

Criteria for Selecting Clinical Sites

Site selection is based on key criteria: prior experience with similar devices, patient recruitment capacity, protocol adherence, and readiness to follow SOPs. Past audit results and compliance with GCP and MDR are also evaluated during site selection.

Feasibility Assessment – Operational Analysis

Prior to study initiation, a comprehensive feasibility analysis is performed, evaluating target population availability, local logistics, timelines, and staffing resources. This helps identify risks to recruitment and study delivery.

Protocol Adaptation to Therapeutic Area

The protocol must align with the therapeutic focus. Patient groups require specific endpoints, monitoring plans, and efficacy metrics. This customization extends to CRFs, statistical plans, and final report structures. A site’s expertise in the therapeutic area minimizes errors and enhances source data quality.

Examples of Clinical Specializations

  • Cardiology – electrotherapy devices, circulatory support systems, ablation catheters.
  • Orthopedics – bone implants, fixation plates, bioresorbable materials.
  • Gynecology and Obstetrics – prenatal diagnostics systems, therapeutic devices.
  • Dermatology – advanced dressings, fractional lasers, chronic wound treatment devices.
  • Pulmonology – ventilators, nebulizers, airflow monitoring systems.
  • Neurology – nerve stimulators, brain-computer interfaces, rehab devices.
  • In Vitro Diagnostics (IVD) – molecular tests, immunoassays, PCR and ELISA systems.

Coordination of Multicenter Studies

For international projects, Pure Clinical provides full regulatory and logistical coordination across sites. Local legislative differences, ethics requirements, and language considerations are addressed. Consistent documentation is ensured via an electronic quality management system (eQMS).

MDR Compliance and Notified Body Readiness

Sites must maintain documentation and operations aligned with MDR requirements, supporting clinical evaluation and PMCF planning. Notified bodies review not only final results but the entire process—highlighting the importance of early collaboration with the notified body.

How Pure Clinical Supports Site Collaboration

Pure Clinical supports sponsors and CROs in establishing and coordinating collaboration with investigational sites for medical device clinical investigations.

Services may include:

  • Selection of investigational sites based on therapeutic area, study requirements, and available expertise,
  • Feasibility assessment, including site capacity and recruitment potential,
  • Adaptation and review of study documentation in line with applicable MDR, ISO 14155, and local requirements,
  • Coordination of monitoring activities and communication with Notified Bodies where applicable,
  • Support with the preparation and review of study documents, including CRFs and Informed Consent Forms (ICFs), as well as clinical or performance study reports where applicable.

The scope of site collaboration is adapted to the study design, participating sites, target markets, and applicable regulatory requirements. Pure Clinical supports the coordination of operational and regulatory activities throughout the study.

FAQ

What is the difference between a clinical site and a Site Management Organization (SMO)?

A clinical site conducts the study based on protocol, with its own infrastructure and staff. An SMO manages operations across multiple sites, ensuring standardized procedures, quality control, and administrative support. Collaborating with an SMO enhances project scalability and streamlines multicenter trial implementation.

Can centers specialized in one therapeutic area effectively conduct interdisciplinary trials?

Yes, but it requires engaging additional specialists, updating SOP documentation, and integrating various analytical systems. For instance, trials involving neurological devices with psychiatric components must account for both neurological and behavioral endpoints, requiring additional training and audit readiness.

What are the risks of underestimating a site’s recruitment capacity?

Underestimating recruitment leads to timeline delays, increased costs, and the need to expand to additional sites. It can also reduce data quality—e.g., by accelerating enrollment of suboptimal participants—and undermine result credibility. Feasibility assessments should include historical performance, local epidemiology, and realistic recruitment metrics.

Can clinical sites participate in multiple medical device trials simultaneously?

Yes, but it requires careful management of scheduling conflicts, staff availability, and procedural compatibility across protocols. Notified bodies assess whether parallel trials compromise data quality or participant safety. There are also requirements for separate documentation and rigorous event tracking for each study.